Brain Res 623, 299-302, (1993). Jansen, K. L., Faull, R. L., Storey, P., & Leslie, R. A. View abstract in PubMed Post navigationPreviousPrevious post:Modification of the N-methyl-Daspartate response by antidepressant sigma receptor ligands.NextNext post:Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: Characterization by ligand binding and photoaffinity labeling.Related PostsAnavex Life Sciences Receives Regulatory Approval from Health Canada and UK MHRA Expanding Phase 2b/3 ANAVEX®2-73 (blarcamesine) into Multinational Clinical Trial for Alzheimer’s DiseaseJune 4, 2020Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX®2-73 (blarcamesine) in Alzheimer’s DiseaseApril 23, 2020Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19March 31, 2020Anavex Life Sciences to Webcast 2020 Annual Meeting of ShareholdersMarch 23, 2020
Anavex Life Sciences Receives Regulatory Approval from Health Canada and UK MHRA Expanding Phase 2b/3 ANAVEX®2-73 (blarcamesine) into Multinational Clinical Trial for Alzheimer’s DiseaseJune 4, 2020
Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX®2-73 (blarcamesine) in Alzheimer’s DiseaseApril 23, 2020
Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19March 31, 2020
